Marcath, Lauren A.
Coe, Taylor D.
Hoylman, Emily K.
Redman, Bruce G.
Hertz, Daniel L. http://orcid.org/0000-0003-0501-1035
Article History
Received: 3 September 2018
Accepted: 12 November 2018
First Online: 22 November 2018
Authors’ information
: Not applicable.
: This study was granted exemption by the University of Michigan IRBMed (HUM00133974). A waiver of informed consent was received for collection of a de-identified dataset. The research involved no more than minimal risk to subjects, would not have impacted the well-being of the subjects, and could not have been practicably carried out without the waiver.
: Not applicable.
: LAM and DLH are working with PEPID Inc. to create a drug interaction screening tool for use during clinical trial enrollment. PEPID Inc. was not involved in the design, conduct, analysis, or sponsorship of this trial, and had no contribution to the writing of this manuscript.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.